South Korea-based luxury goods resale platform Kream raised a ~$168M Series C led by Altos Ventures at a ~$742M valuation, up from ~$306M in October 2021 (Kate Park/TechCrunch)March 23, 2023
Business Live updates: Shares in Eisai jump 9% on US approval of Alzheimer’s drugBy Public NewsJanuary 10, 20230 Reside updates: Shares in Eisai leap 9% on US approval of Alzheimer’s drug
World Alzheimer’s drug succeeds in slowing cognitive decline, makers Eisai and Biogen say | News24By Public NewsSeptember 28, 20220 A brand new Alzheimer’s drug created by Biogen and Eisai Co Ltd has proven promising outcomes. TEK IMAGE/SCIENCE…
